RESYL SYRUP

Riik: Iisrael

keel: inglise

Allikas: Ministry of Health

Toimeaine:

GUAIFENESIN

Saadav alates:

DEVRIES & CO. LTD

ATC kood:

R05CA03

Ravimvorm:

SYRUP

Koostis:

GUAIFENESIN 100 MG / 5 ML

Manustamisviis:

PER OS

Retsepti tüüp:

Not required

Valmistatud:

STADA ARZNEIMITTEL AG, GERMANY

Terapeutiline rühm:

GUAIFENESIN

Terapeutiline ala:

GUAIFENESIN

Näidustused:

Expectorant, relieves cough.

Loa andmise kuupäev:

2014-01-31

Infovoldik

https://sideeffects.health.gov.il
STADA Arzneimittel AG, Stadastrasse 2-18,
61118 Bad-Vilbel, Germany
،32 لزرﺑھ عرﺎﺷ ،.ض.م هؤﺎﻛرﺷو سﯾرﻔﯾد
بﯾﺑأ-لﺗ
STADA Arzneimittel AG,
Stadastrasse 2-18, 61118 Bad-Vilbel, Germany
.ﺔﺣﺻﻟا ةرازو تﺎﻣﯾﻠﻌﺗ ﻖﻓو 2021
رﺎﯾأ ﻲﻓ ﺎﮭﺛﯾدﺣﺗ مﺗ
https://sideeffects.health.gov.il
Devries & Co. Ltd., 32 Habarzel st., Tel-Aviv
Revised in May 2021 according to MoH guidelines.
62000000061063
9299155 2012 IL
10 mm
5 mm
5 mm
157.5 mm
10 mm
Verso
210 mm
420 mm
210 mm

Toote omadused

RESYL
® SYRUP
_COMPOSITION _
_Active substance_: guaifenesin.
_Excipients_: Purified Water, Sorbitol liquid (non crystallising),
Ethanol 96%, Glycerol, Aroma, Saccharin
Sodium.
_PHARMACEUTICAL FORM AND QUANTITY OF THE ACTIVE SUBSTANCE PER UNIT _
_Syrup: _5 mL contains 100 mg of guaifenesin.
_INDICATIONS/POSSIBLE USES _
Expectorant, relieves cough.
_POSOLOGY/USE _
_Adults: _5 to 10 mL 4 times per day.
Resyl Syrup contains 6% alcohol by volume (corresponding to 5%
weight/vol.). Resyl Syrup is not suitable
for children or adolescents.
Use the graduated measuring cup included in the package. Wash and dry
the graduated measuring cup
after each use and between each user.
In addition to treatment, drinking plenty of liquid is recommended
(e.g. infusions, fruit juices).
_CONTRAINDICATIONS _
Hypersensitivity to the active substance or to one of the excipients
in the composition.
Intolerance to fructose, for example, in case of hereditary
fructose-1.6-diphosphatase intolerance
(fructose is the result of the degradation of the sweetener sorbitol).
_WARNINGS AND PRECAUTIONS _
Caution should be used in case of gastrointestinal disorders,
myasthenia gravis, or with limited kidney
function.
In case of bronchospasms or hypersensitivity reactions, treatment
should be discontinued immediately,
and the doctor informed.
In the following cases, patients must also contact their doctor:
•
respiratory failure,
•
cough with bloody expectorate or production of excessive bronchial
mucus,
•
persistent or chronic cough, e.g., in smokers, asthmatics, in case of
chronic bronchitis or
emphysema,
•
if the cough lasts more than 7 days, relapses, or is accompanied by
fever, a skin rash, or
persistent headaches.
Resyl Syrup contains 5% weight/volume of alcohol. Adults take up to
470 mg of alcohol (10 mL) per
dose.
A risk for health exists, among others, for individuals with liver
disease, alcoholics, epileptics, individuals
with brain damage, pregnant or breast-feeding women, and children. The
effect of other medicinal
products can be stre